• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和肿瘤肾脏组织中易化性葡萄糖转运蛋白的差异表达。

Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.

作者信息

Suganuma Nobuyasu, Segade Fernando, Matsuzu Kenichi, Bowden Donald W

机构信息

Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

出版信息

BJU Int. 2007 May;99(5):1143-9. doi: 10.1111/j.1464-410X.2007.06765.x.

DOI:10.1111/j.1464-410X.2007.06765.x
PMID:17437443
Abstract

OBJECTIVE

To investigate the differences in the pattern of glucose transporter (GLUT) gene expression between normal and tumour tissues and among histological subtypes of renal cell carcinomas (RCCs), as malignant cells are characterized by increased glucose uptake and use.

MATERIALS AND METHODS

Enhanced glucose uptake probably depends on the overexpression of GLUT, usually GLUT1 and/or GLUT3, but there are few comprehensive studies to evaluate the relative expression pattern and level of GLUT in normal and tumour kidney tissues, especially of the recently identified GLUT genes. In all, 71 kidney surgical samples were evaluated using reverse transcriptase-polymerase chain reaction (RT-PCR) for GLUT1-14 in normal and tumour (clear cell, papillary and chromophobe RCC, and oncocytoma) tissues. The expression levels for GLUT1-5, 9, 10 and 12 were quantified by real-time quantitative PCR.

RESULTS

The RT-PCR results showed that normal kidney tissue expresses all the GLUT isoforms. In clear cell RCC GLUT1 expression increased (P<0.001) while GLUT4, 9 and 12 decreased (P<0.001). In papillary RCC there were no significant increases in GLUT expression, with only GLUT12 significantly expressed at lower levels (P<0.001). In chromophobe RCC the expression of GLUT4 increased (P<0.05), and GLUT2 and 5 decreased (P<0.01), whereas in oncocytoma tissue there were no significant changes in the expression of GLUT1 (P<0.01), 2, 5, 9 (P<0.001) and 10 (P<0.05).

CONCLUSIONS

These results suggest that high-affinity GLUTs might have a major role in enhanced glucose uptake in kidney tumours, and that histopathological types are characterized by specific patterns of GLUT expression.

摘要

目的

鉴于恶性细胞具有葡萄糖摄取和利用增加的特征,研究正常组织与肿瘤组织之间以及肾细胞癌(RCC)组织学亚型之间葡萄糖转运蛋白(GLUT)基因表达模式的差异。

材料与方法

葡萄糖摄取增加可能依赖于GLUT的过表达,通常是GLUT1和/或GLUT3,但很少有综合研究评估正常和肿瘤肾脏组织中GLUT的相对表达模式和水平,尤其是最近发现的GLUT基因。总共71份肾脏手术样本通过逆转录聚合酶链反应(RT-PCR)评估正常和肿瘤(透明细胞、乳头状和嫌色性RCC以及嗜酸细胞瘤)组织中GLUT1-14的表达。通过实时定量PCR对GLUT1-5、9、10和12的表达水平进行定量。

结果

RT-PCR结果显示正常肾脏组织表达所有GLUT异构体。在透明细胞RCC中,GLUT1表达增加(P<0.001),而GLUT4、9和12表达降低(P<0.001)。在乳头状RCC中,GLUT表达无显著增加,只有GLUT12表达显著降低(P<0.001)。在嫌色性RCC中,GLUT4表达增加(P<0.05),GLUT2和5表达降低(P<0.01),而在嗜酸细胞瘤组织中,GLUT1(P<0.01)、2、5、9(P<0.001)和10(P<0.05)的表达无显著变化。

结论

这些结果表明,高亲和力GLUT可能在肾肿瘤葡萄糖摄取增加中起主要作用,并且组织病理学类型具有特定的GLUT表达模式。

相似文献

1
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.正常和肿瘤肾脏组织中易化性葡萄糖转运蛋白的差异表达。
BJU Int. 2007 May;99(5):1143-9. doi: 10.1111/j.1464-410X.2007.06765.x.
2
Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.人甲状腺癌细胞系和原发性肿瘤中易化性葡萄糖转运蛋白(GLUTs)的表达分析。
Mol Cell Endocrinol. 2008 Sep 10;291(1-2):57-62. doi: 10.1016/j.mce.2008.05.003. Epub 2008 May 14.
3
The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.前列腺干细胞抗原在人透明细胞肾细胞癌中的表达:定量逆转录聚合酶链反应分析
BJU Int. 2006 Sep;98(3):668-73. doi: 10.1111/j.1464-410X.2006.06350.x.
4
Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.葡萄糖转运蛋白-1在肾细胞癌中的表达及其与缺氧诱导因子-1α的相关性。
BJU Int. 2008 Feb;101(4):480-4. doi: 10.1111/j.1464-410X.2007.07238.x. Epub 2007 Oct 8.
5
Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and corpus luteum.牛卵泡和黄体中葡萄糖转运蛋白(GLUT)1、3和4的基因表达。
J Endocrinol. 2006 Jan;188(1):111-9. doi: 10.1677/joe.1.06210.
6
Glucose transporter expression in English sparrows (Passer domesticus).家麻雀(Passer domesticus)中葡萄糖转运蛋白的表达
Comp Biochem Physiol B Biochem Mol Biol. 2006 Jul;144(3):263-70. doi: 10.1016/j.cbpb.2005.12.027. Epub 2006 Mar 27.
7
C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.肾嗜酸细胞瘤和嫌色肾细胞癌中的C-kit表达。
Hum Pathol. 2005 Mar;36(3):262-8. doi: 10.1016/j.humpath.2005.01.011.
8
Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.透明细胞和乳头状肾细胞癌中胰岛素样生长因子家族成员的信使核糖核酸和蛋白质表达改变。
Int J Urol. 2005 Jan;12(1):17-28. doi: 10.1111/j.1442-2042.2004.00993.x.
9
Facilitative glucose transporter expression in human cancer tissue.人癌组织中易化型葡萄糖转运蛋白的表达
Br J Biomed Sci. 1999;56(4):285-92.
10
Expression of facilitative glucose transporters in gastric tumors.促葡萄糖转运蛋白在胃肿瘤中的表达。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2683-9.

引用本文的文献

1
Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach.将葡萄糖转运蛋白(GLUTs和SGLTs)视为对抗癌症的新型干预手段:药物发现视角与靶向方法
Curr Drug Targets. 2025;26(2):109-131. doi: 10.2174/0113894501335877240926101134.
2
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.循环 microRNA-155-3p 水平可预测转移性肾细胞癌患者一线免疫治疗的反应。
Sci Rep. 2024 Apr 13;14(1):8603. doi: 10.1038/s41598-024-59337-4.
3
Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas.
定量蛋白质组学鉴定出一种与垂体腺瘤 EMT 相关的新型侵袭性生物标志物。
Front Endocrinol (Lausanne). 2023 Mar 3;14:1137648. doi: 10.3389/fendo.2023.1137648. eCollection 2023.
4
Endoplasmic Reticulum Stress in Renal Cell Carcinoma.内质网应激与肾细胞癌。
Int J Mol Sci. 2023 Mar 3;24(5):4914. doi: 10.3390/ijms24054914.
5
Nutrient transporters: connecting cancer metabolism to therapeutic opportunities.营养转运蛋白:将癌症代谢与治疗机会联系起来。
Oncogene. 2023 Mar;42(10):711-724. doi: 10.1038/s41388-023-02593-x. Epub 2023 Feb 4.
6
Glucose transporters as markers of diagnosis and prognosis in cancer diseases.葡萄糖转运蛋白作为癌症诊断和预后的标志物。
Oncol Rev. 2022 Feb 22;16(1):561. doi: 10.4081/oncol.2022.561.
7
Human Glucose Transporters in Renal Glucose Homeostasis.人类葡萄糖转运蛋白在肾脏葡萄糖稳态中的作用。
Int J Mol Sci. 2021 Dec 16;22(24):13522. doi: 10.3390/ijms222413522.
8
Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro.上皮间质转化调节因子 TWIST1 转录因子通过上调 GLUT1、GLUT3 和 GLUT12 体外刺激葡萄糖摄取。
In Vitro Cell Dev Biol Anim. 2021 Dec;57(10):933-943. doi: 10.1007/s11626-021-00635-w. Epub 2021 Nov 17.
9
The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC.透明细胞肾细胞癌的独特性:ccRCC中葡萄糖代谢和脂质代谢的过程及异常总结
Front Oncol. 2021 Sep 15;11:727778. doi: 10.3389/fonc.2021.727778. eCollection 2021.
10
Glucose Transporters as a Target for Anticancer Therapy.葡萄糖转运蛋白作为抗癌治疗的靶点
Cancers (Basel). 2021 Aug 20;13(16):4184. doi: 10.3390/cancers13164184.